Search research articles
Contact Us
Filters
Showing results (41-50 of 2,585) with videos related to
Page
of 259
Sort By:
Science (New York, N.Y.)
|
May 9, 1986
The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes
T A Waldmann
Leukemia
|
August 1, 1993
1992 Stohlman Memorial Lecture: targeting the IL-2 receptor
T A Waldmann
Arthritis Research & Therapy
|
July 1, 2004
Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
Thomas A Waldmann
Important Advances in Oncology
|
January 1, 1994
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma
T A Waldmann
The Netherlands Journal of Medicine
|
October 1, 1991
Clinical immunology: past, present and future challenges and prospects
T A Waldmann
Tierarztliche Praxis
|
April 1, 1992
[Provision and measures for sanitation in piglet breeding operations with latent swine dysentery]
K H Waldmann
Journal of Clinical Immunology
|
January 12, 2007
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey
Thomas A Waldmann
Cancer Immunology Research
|
March 5, 2015
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy
Thomas A Waldmann
Psychiatrische Praxis
|
September 17, 1998
[Implementation of the Rodewisch Theses in East Germany--attempted analysis from the current viewpoint]
K D Waldmann
Cold Spring Harbor Perspectives in Biology
|
November 5, 2017
Cytokines in Cancer Immunotherapy
Thomas A Waldmann
Page
of 259
Search research articles
Search
Showing results (41-50 of 2,585) with videos related to
Sort By:
Page
of 259
Science (New York, N.Y.)
|
May 9, 1986
The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes
T A Waldmann
Leukemia
|
August 1, 1993
1992 Stohlman Memorial Lecture: targeting the IL-2 receptor
T A Waldmann
Arthritis Research & Therapy
|
July 1, 2004
Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
Thomas A Waldmann
Important Advances in Oncology
|
January 1, 1994
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma
T A Waldmann
The Netherlands Journal of Medicine
|
October 1, 1991
Clinical immunology: past, present and future challenges and prospects
T A Waldmann
Tierarztliche Praxis
|
April 1, 1992
[Provision and measures for sanitation in piglet breeding operations with latent swine dysentery]
K H Waldmann
Journal of Clinical Immunology
|
January 12, 2007
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey
Thomas A Waldmann
Cancer Immunology Research
|
March 5, 2015
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy
Thomas A Waldmann
Psychiatrische Praxis
|
September 17, 1998
[Implementation of the Rodewisch Theses in East Germany--attempted analysis from the current viewpoint]
K D Waldmann
Cold Spring Harbor Perspectives in Biology
|
November 5, 2017
Cytokines in Cancer Immunotherapy
Thomas A Waldmann
Page
of 259